Bio Protocol to Launch First BioAgent Sale Project Aubrai, 20% of Total Supply Allocated for Sale

Foresight News reports that the decentralized science (DeSci) platform Bio Protocol will launch its first BioAgent sale project, Aubrai. The total supply of Aubrai is 2 million tokens, of which 20% will be allocated for sale, 6% for the liquidity pool, 15% for the treasury, 20.1% for initial backers, 10% for LEVF, 22% for VitaDAO, and 6.9% for Bio Protocol. The token TGE will take place on August 25. Aubrai is a decentralized scientific agent jointly developed by VitaDAO and BIO, aimed at combating human aging.